eXmoor Pharma
Bristol, United Kingdom exmoorpharma.com From their website, Nov 2026
- GMP
Work here? Claim this listing
About
eXmoor Pharma is a cell and gene therapy CDMO that combines consultancy, process development, analytical services, GMP manufacturing, and facility design support. It serves biotech innovators, academic groups, biopharma companies, and investors from its Bristol, UK site, supporting development through commercialisation.
Services
CMC Consulting & Strategy
Helps define CMC plans, align development with regulatory expectations, and create roadmaps for long-term success.
Cost of Goods
Provides cost modelling to support manufacturing decisions, pricing strategy, market access, and scale-up planning.
Investor & Technical Due Diligence
Assesses scientific, technical, regulatory, and commercial risks to support investment and acquisition decisions.
GMP Compliance Consulting & QP Services
Provides GMP oversight, batch certification, inspection readiness, and compliance support through Qualified Persons.
Interim Leadership Positions
Supplies interim executives and technical leaders to fill short-term leadership gaps in technical, regulatory, and manufacturing roles.
Process Development
Optimises and scales cell and gene therapy processes for development, tech transfer, and commercialisation.
Analytical Services
Generates analytical data to support product safety, efficacy, regulatory compliance, batch release, and stability studies.
GMP Manufacturing
Provides regulatory-compliant GMP manufacturing for cell and gene therapy products.
5 more services
- Facility Design & Process Engineering
- Clinical Manufacturing
- Commercial Manufacturing
- Cell Banking
- Fill Finish
Capabilities
- Assays and studies
- Process development
- Cell therapy
- Fill-finish
- AAV
- Bioreactors
- Lentivirus
9 more
- Analytical development
- Physiochemical testing
- Molecular testing
- Biological testing
- Potency testing
- Sterility testing
- Purity testing
- Batch release testing
- Stability studies
- Scale and capacity
- 65,000 ft² facility
- 12,000 ft² planned expansion
- Four independent Grade C clean rooms
- 2 x 200L bioreactor scale
- 5 autologous cell therapy stations
- 500–1000L viral vector processes
- Therapeutic areas
- Cell and gene therapy
- Advanced therapies
Instruments and platforms
- Grade A isolators
- QC laboratories
Modalities and species
- Modalities
- mRNA
- Viral vector
- Cell therapy
- LNP / formulation
- Species and models
- iPSC / organoids
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Details
- Type
- CRDMO
- Founded
- 2004
- Size
- 51-200 employees
- Based in
- Bristol, United Kingdom
- Serves
- Worldwide, global